Metabolomic Strategy for Studying the Intervention and the Synergistic Effects of the Shexiang Baoxin Pill for Treating Myocardial Infarction in Rats

<table>CK and LDH results in rat serum from MI group. LDH: lactate dehydrogenase and CK: and creatine kinases. (A) sham group, (B) MI group, (C) SBP group, (D) SFSBP group, (E) ginsenoside Re, (F) ginsenoside Rb1, (G) bufalin group, (H) cinnamic acid group, (I) muscone group, (J) borneol group, and (K) cholic acid group. **<i>P </i>&lt; 0.01 versus MI group and <sup>##</sup><i>P </i>&lt; 0.01 versus sham group.</table>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: Metabolomic Strategy for Studying the Intervention and the Synergistic Effects of the Shexiang Baoxin Pill for Treating Myocardial Infarction in Rats 

Figure 1 | Metabolomic Strategy for Studying the Intervention and the Synergistic Effects of the Shexiang Baoxin Pill for Treating Myocardial Infarction in Rats 